June 1, 2017
The common shares of Supreme Pharmaceuticals Inc. will be delisted at the market close, June 5, 2017.
Supreme Pharmaceuticals will continue to trade on the TSX Venture Exchange.
Date: Market close, June 5, 2017
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: [email protected]